Rovin Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Rovin Capital's AMGN Position: Q4 2025 in Review
Rovin Capital increased its Amgen (AMGN) stake by 82% in Q4 2025, buying an estimated $411K and bringing the position to 2,873 shares worth $940K. The position accounts for 0.25% of the portfolio, ranked #74.
Rovin Capital first reported a position in AMGN in Q3 2023 and has held it in 8 quarters since. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Rovin Capital held 2,873 shares of Amgen worth $940K as of Q4 2025.
- Rovin Capital bought 1,296 Amgen shares in Q4 2025, an estimated $411K.
- Amgen made up 0.25% of Rovin Capital's portfolio in Q4 2025, its #74 holding.
- Rovin Capital first reported a position in Amgen in Q3 2023 and has held it in 8 quarters since.
- 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Rovin Capital's 13F filing for Q4 2025, filed 9 Feb 2026.